194 related articles for article (PubMed ID: 34908119)
21. Arbutin suppresses osteosarcoma progression via miR-338-3p/MTHFD1L and inactivation of the AKT/mTOR pathway.
Wang CQ; Wang XM; Li BL; Zhang YM; Wang L
FEBS Open Bio; 2021 Jan; 11(1):289-299. PubMed ID: 33146000
[TBL] [Abstract][Full Text] [Related]
22. Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma.
Lee D; Xu IM; Chiu DK; Lai RK; Tse AP; Lan Li L; Law CT; Tsang FH; Wei LL; Chan CY; Wong CM; Ng IO; Wong CC
J Clin Invest; 2017 May; 127(5):1856-1872. PubMed ID: 28394261
[TBL] [Abstract][Full Text] [Related]
23. The MTHFD1L gene rs11754661 marker is associated with susceptibility to Alzheimer's disease in the Chinese Han population.
Ren RJ; Wang LL; Fang R; Liu LH; Wang Y; Tang HD; Deng YL; Xu W; Wang G; Chen SD
J Neurol Sci; 2011 Sep; 308(1-2):32-4. PubMed ID: 21741665
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos.
Pike ST; Rajendra R; Artzt K; Appling DR
J Biol Chem; 2010 Feb; 285(7):4612-20. PubMed ID: 19948730
[TBL] [Abstract][Full Text] [Related]
25. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
26. Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome.
Hubacek JA; Staněk V; Gebauerová M; Poledne R; Aschermann M; Skalická H; Matoušková J; Kruger A; Pěnička M; Hrabáková H; Veselka J; Hájek P; Lánská V; Adámková V; Pitˇha J
Mol Biol Rep; 2015 Aug; 42(8):1289-93. PubMed ID: 25809277
[TBL] [Abstract][Full Text] [Related]
27. The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma.
Yang YS; Yuan Y; Hu WP; Shang QX; Chen LQ
Scand J Gastroenterol; 2018 May; 53(5):533-540. PubMed ID: 29171320
[TBL] [Abstract][Full Text] [Related]
28. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
29. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses.
Hameed Y
J Cancer Res Ther; 2023 Oct; 19(7):1852-1864. PubMed ID: 38376289
[TBL] [Abstract][Full Text] [Related]
30. Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.
Naj AC; Beecham GW; Martin ER; Gallins PJ; Powell EH; Konidari I; Whitehead PL; Cai G; Haroutunian V; Scott WK; Vance JM; Slifer MA; Gwirtsman HE; Gilbert JR; Haines JL; Buxbaum JD; Pericak-Vance MA
PLoS Genet; 2010 Sep; 6(9):e1001130. PubMed ID: 20885792
[TBL] [Abstract][Full Text] [Related]
31. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
Front Immunol; 2022; 13():903461. PubMed ID: 35663977
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis Reveals Deoxyribonuclease 1 as a Potential Prognostic and Diagnostic Biomarker in Human Cancers.
Eletr LF; Ibnouf SH; Salih TA; Ibrahim HI; Mustafa MI; Alhashmi NA; Alfaki M
Cureus; 2024 Mar; 16(3):e56171. PubMed ID: 38618458
[TBL] [Abstract][Full Text] [Related]
33. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19.
Yang J; Li H; Hu S; Zhou Y
Aging (Albany NY); 2020 Apr; 12(8):6518-6535. PubMed ID: 32339157
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation of murine NADP(+)-dependent methylenetetrahydrofolate dehydrogenase-cyclohydrolase-synthetase.
Peri KG; MacKenzie RE
FEBS Lett; 1991 Dec; 294(1-2):113-5. PubMed ID: 1720740
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
36. Decoding signal transducer and activator of transcription 1 across various cancers through data mining and integrative analysis.
Munir H; Rana AT; Faheem M; Almutairi SM; Siddique T; Asghar S; Abdel-Maksoud MA; Mubarak A; Elkhamisy FAA; Studenik CR; Yaz H
Am J Transl Res; 2022; 14(6):3638-3657. PubMed ID: 35836889
[TBL] [Abstract][Full Text] [Related]
37. Folate network genetic variation, plasma homocysteine, and global genomic methylation content: a genetic association study.
Wernimont SM; Clark AG; Stover PJ; Wells MT; Litonjua AA; Weiss ST; Gaziano JM; Tucker KL; Baccarelli A; Schwartz J; Bollati V; Cassano PA
BMC Med Genet; 2011 Nov; 12():150. PubMed ID: 22103680
[TBL] [Abstract][Full Text] [Related]
38. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
39. hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles.
Fischl H; Neve J; Wang Z; Patel R; Louey A; Tian B; Furger A
Nucleic Acids Res; 2019 Aug; 47(14):7580-7591. PubMed ID: 31147722
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes.
Khan R; Pari B; Puszynski K
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
